home / stock / evok / evok news

EVOK News and Press, Evoke Pharma Inc.

Stock Information
Company Name: Evoke Pharma Inc.
Stock Symbol: EVOK
Market: NASDAQ
Website: evokepharma.com
Menu
EVOK EVOK Quote EVOK Short EVOK News EVOK Articles EVOK Message Board
Get EVOK Alerts

News, Short Squeeze, Breakout and More Instantly...
EVOK - US Companies Moving the Markets, Morning edition
Mon, Jun 24, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
EVOK - US Companies Moving the Markets, Morning edition
Mon, Jun 17, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...

EVOK - Evoke Pharma appoints Mark Kowieski as CFO

2024-06-17 09:03:05 ET More on Evoke Pharma Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma Read the full article on Seeking Alpha For further details see: Evoke ...

EVOK - Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI

Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK)...
EVOK - Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference

SOLANA BEACH, Calif., May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that its abstra...

EVOK - Evoke Pharma GAAP EPS of -$0.17 beats by $0.04, revenue of $1.73M misses by $0.41M

2024-05-15 09:57:02 ET More on Evoke Pharma Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript Seeking Alpha’s Quant Rating on Evoke Pharma Historical earnings data for Evoke Pharma Financial information for Evoke Pharma Read the full...

EVOK - Evoke Pharma Reports First Quarter 2024 Financial Results

114% year-over-year increase in net product sales 70% prescriber growth in Q1 2024 compared to Q4 2023 Growing sales metrics reaffirms company’s $14M net revenue guidance for 2024 SOLANA BEACH, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a ...
EVOK - Evoke Pharma to Host Virtual Key Opinion Leader (KOL) Webinar on the Evolving Landscape of Gastroparesis: GIMOTI, Hospitalizations, and GLP-1 Medications

SOLANA BEACH, Calif., April 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced it will host a virtua...

EVOK - Evoke Pharma names Matthew D'Onofrio as new CEO

2024-03-21 16:21:33 ET More on Evoke Pharma Evoke Pharma, Inc. (EVOK) Q4 2023 Earnings Call Transcript Evoke Pharma down 28%, prices $30M offering Read the full article on Seeking Alpha For further details see: Evoke Pharma names Matthew D’Onofrio ...

EVOK - Evoke Pharma Announces Senior Leadership Transition with Promotion of Matthew J. D'Onofrio to Chief Executive Officer

SOLANA BEACH, Calif., March 21, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ® (metoclopramide) nasal spray, announced that Matthew J. D’...
Next 10